Valuation: Bioretec Oy

Market Cap 28.71M 32.16M 26.52M 24.05M 45.04M 3.05B 45.7M 319M 126M 1.6B 121M 118M 5.05B P/E 2025
-0.07x
P/E 2026 * -2.14x
Enterprise Value 24.31M 27.23M 22.46M 20.37M 38.14M 2.58B 38.7M 270M 107M 1.35B 102M 100M 4.27B EV / Sales 2025
7.03x
EV / Sales 2026 * 4.24x
Free-Float
99.48%
Yield 2025 *
-
Yield 2026 * -
1 week-4.46%
Current month-20.15%
1 month-21.32%
3 months+7.00%
6 months-2.73%
Current year-96.43%
1 week 0.02
Extreme 0.0208
0.03
1 month 0.02
Extreme 0.0208
0.03
Current year 0.01
Extreme 0.0108
0.66
1 year 0.01
Extreme 0.0108
1.4
3 years 0.01
Extreme 0.0108
3.01
5 years 0.01
Extreme 0.0108
3.75
10 years 0.01
Extreme 0.0108
3.75
Manager TitleAgeSince
Chief Executive Officer 48 2025-05-14
Director of Finance/CFO - 2026-10-05
Chief Operating Officer - 2025-08-17
Director TitleAgeSince
Director/Board Member 67 2017-12-31
Director/Board Member 54 2022-04-12
Chairman - 2025-03-20
Date Insider Type Main position Quantity % Market Cap. Importance
6/25/25
Stephen Industries, Inc Oy
BuyCompany 500,000 1.6243%
6/10/25
Stephen Industries, Inc Oy
BuyCompany 639,092 2.0761%
4/9/25 Free

Director

25,000 0.1018%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.46%-98.46%-99.11% 32.17M
+1.16%-0.94%-18.95%+7.15% 177B
-1.22%-0.04%-0.51%+31.24% 118B
+0.02%+4.75%-20.91%+15.60% 118B
+2.29%+21.86%-41.81%+11.12% 91.21B
-2.21%-3.05%+0.06%+75.36% 64.59B
-1.06%+4.59%+13.36%+78.58% 56.13B
-0.75%+2.66%+5.74%-23.09% 54.59B
-1.13%+2.41%-11.58%+31.24% 43.6B
+0.17%+5.12%-4.89%-10.48% 33.95B
Average -0.27%+3.35%-17.80%+11.76% 75.75B
Weighted average by Cap. -0.02%+3.55%-12.28%+22.22%

Financials

2025 2026 *
Net sales 3.8M 4.26M 3.51M 3.18M 5.96M 404M 6.05M 42.26M 16.74M 212M 15.97M 15.63M 668M 5.1M 5.71M 4.71M 4.27M 8M 542M 8.12M 56.72M 22.47M 284M 21.44M 20.98M 896M
Net income -9.6M -10.75M -8.87M -8.04M -15.06M -1.02B -15.28M -107M -42.29M -535M -40.35M -39.49M -1.69B -8.7M -9.74M -8.04M -7.29M -13.65M -925M -13.85M -96.76M -38.32M -485M -36.57M -35.79M -1.53B
Net Debt -4.4M -4.93M -4.06M -3.69M -6.9M -468M -7M -48.94M -19.38M -245M -18.49M -18.1M -773M -7.1M -7.95M -6.56M -5.95M -11.14M -755M -11.3M -78.96M -31.28M -396M -29.84M -29.21M -1.25B
Projected Income Statement - Annual - Bioretec Oy
Logo Bioretec Oy
Bioretec Oy is a Finland-based medical device manufacturer company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The Company operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.
Employees
-
Date Price Change Volume
26-10-23 €0.0214 0.00% 1,183,014
26-10-22 €0.0214 -0.93% 716,555
26-10-21 €0.0216 +0.93% 776,546
26-10-20 €0.0214 -2.73% 854,322
26-10-19 €0.0220 -1.79% 833,334
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
1
Last Close Price
0.0214EUR
Average target price
0.0200EUR
Spread / Average Target
-6.54%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Bioretec Oy
  1. Stock Market
  2. Stocks
  3. BRETEC Stock